Answers are grounded in this paper and cite their sources.
Case report demonstrates paraneoplastic cerebellar degeneration associated with metastatic ovarian adenocarcinoma, highlighting early cancer detection's importance.
BACKGROUND Paraneoplastic cerebellar degeneration (PCD) is a rare but debilitating autoimmune neurological syndrome often associated with gynecological malignancies, particularly ovarian cancer. PCD may precede the diagnosis of the underlying tumor, and its early recognition is crucial to improving patient outcomes. METHODS We present a case of a 61-year-old woman from Nepal who developed progressive slurred speech and unsteady gait. Initial neurological work-up, cerebrospinal fluid analysis, and serum biomarkers were inconclusive for metastasis or infection. Further investigations, including imaging, histopathology, and immunohistochemistry, were conducted. RESULTS The patient was found to have elevated CA-125 and a strongly positive anti-Yo antibody. Imaging revealed recurrent pelvic masses with metastases. Biopsy confirmed metastatic ovarian adenocarcinoma. Brain MRI later showed cerebellar atrophy and T2/FLAIR hyperintensities. The patient was diagnosed with paraneoplastic cerebellar degeneration secondary to metastatic ovarian carcinoma. CONCLUSION This case underscores the significance of considering paraneoplastic syndromes in patients with unexplained cerebellar symptoms. Timely evaluation and recognition of PCD can facilitate early cancer detection, allowing for earlier intervention and potentially limiting irreversible neurological damage.
No takes yet. Share an insight, caveat, or question.
Joshi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: